Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
The morbidity and mortality of lung cancer rank the first place among all the malignant tumor. According to the histopathological characteristics, lung cancer is divided into non-small cell lung cancer (NSCLC) and small cell lung cancer. Only 20% patients diagnosed with NSCLC have the chance for sur...
Main Authors: | Bo LIU, Fengxia DING, Shuangqiang YANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2015-06-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.08 |
Similar Items
-
Advance of Postoperative Adjuvant Therapy in Non-small Cell Lung Cancer
by: Na HAN, et al.
Published: (2014-06-01) -
Effect of Adjuvant Chemotherapy on DFS for Patients with Stage I NSCLC
by: Shengzu PENG, et al.
Published: (2017-06-01) -
The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer
by: Xiangtao YAN, et al.
Published: (2011-03-01) -
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
by: Bonomi Maria, et al.
Published: (2011-12-01) -
Adjuvant chemotherapy options for early stage non-small cell lung cancer
by: Manali ePatel, et al.
Published: (2011-11-01)